These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 37783206)
1. Risk Factors for Fractures in Renal Transplantation: A Population-Based Cohort Study. Tsai HL; Lin TC; Lin NC; Yang HH; Chang JW Am J Nephrol; 2023; 54(11-12):498-507. PubMed ID: 37783206 [TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus after kidney transplantation in Japanese patients: The Japan Academic Consortium of Kidney Transplantation study. Okumi M; Unagami K; Hirai T; Shimizu T; Ishida H; Tanabe K; Int J Urol; 2017 Mar; 24(3):197-204. PubMed ID: 27862344 [TBL] [Abstract][Full Text] [Related]
3. Is mycophenolate mofetil less safe than azathioprine in elderly renal transplant recipients? Johnson DW; Nicol DL; Purdie DM; Preston JM; Brown AM; Hawley CM; Campbell SB; Wall D; Griffin AD; Isbel NM Transplantation; 2002 Apr; 73(7):1158-63. PubMed ID: 11965051 [TBL] [Abstract][Full Text] [Related]
4. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719 [TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group. Miller J; Mendez R; Pirsch JD; Jensik SC Transplantation; 2000 Mar; 69(5):875-80. PubMed ID: 10755543 [TBL] [Abstract][Full Text] [Related]
7. Survival Associated With Sirolimus Plus Tacrolimus Maintenance Without Induction Therapy Compared With Standard Immunosuppression After Lung Transplant. Wijesinha M; Hirshon JM; Terrin M; Magder L; Brown C; Stafford K; Iacono A JAMA Netw Open; 2019 Aug; 2(8):e1910297. PubMed ID: 31461151 [TBL] [Abstract][Full Text] [Related]
8. Risk factors for fractures following liver transplantation: a population-based cohort study. Chang JW; Yang HH; Lin NC; Kuo FC; Lin TC; Tsai HL Ann Med; 2023 Dec; 55(1):2230871. PubMed ID: 37455447 [TBL] [Abstract][Full Text] [Related]
9. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option? Höcker B; Tönshoff B Paediatr Drugs; 2011 Feb; 13(1):49-69. PubMed ID: 21162600 [TBL] [Abstract][Full Text] [Related]
10. Outcomes of Everolimus Plus Standard-Dose Tacrolimus Immunosuppression in De Novo Kidney Transplant: A Retrospective, Single-Center Study of 225 Transplants. Okabe Y; Noguchi H; Sato Y; Mei T; Kaku K; Ueki K; Tsuchimoto A; Nakamura M Exp Clin Transplant; 2022 Mar; 20(4):362-369. PubMed ID: 35475420 [TBL] [Abstract][Full Text] [Related]
11. Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia. Knight RJ; Graviss EA; Nguyen DT; Kuten SA; Patel SJ; Gaber L; Gaber AO Clin Transplant; 2018 Jun; 32(6):e13265. PubMed ID: 29676018 [TBL] [Abstract][Full Text] [Related]
13. A Prospective Randomized, Comparative Trial of High-Dose Mizoribine Versus Mycophenolate Mofetil in Combination With Tacrolimus and Basiliximab for Living Donor Renal Transplant: A Multicenter Trial. Ishida H; Takahara S; Amada N; Tomikawa S; Chikaraishi T; Takahashi K; Uchida K; Akiyama T; Tanabe K; Toma H; Exp Clin Transplant; 2016 Oct; 14(5):518-525. PubMed ID: 27733107 [TBL] [Abstract][Full Text] [Related]
14. Trends in maintenance immunosuppressive drugs used in taiwanese kidney transplant recipients: an analysis of the national health insurance research database. Tsai SF; Cheng CY; Shu KH; Wu MJ Transplant Proc; 2012 Jan; 44(1):190-2. PubMed ID: 22310612 [TBL] [Abstract][Full Text] [Related]
15. Use of De Novo mTOR Inhibitors in Hypersensitized Kidney Transplant Recipients: Experience From Clinical Practice. Cucchiari D; Molina-Andujar A; Montagud-Marrahi E; Revuelta I; Rovira J; Ventura-Aguiar P; Piñeiro GJ; De Sousa-Amorim E; Esforzado N; Cofán F; Torregrosa JV; Ugalde-Altamirano J; Ricart MJ; Centellas-Pérez FJ; Solè M; Martorell J; Ríos J; Campistol JM; Diekmann F; Oppenheimer F Transplantation; 2020 Aug; 104(8):1686-1694. PubMed ID: 32732848 [TBL] [Abstract][Full Text] [Related]
16. Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. Chhabra D; Skaro AI; Leventhal JR; Dalal P; Shah G; Wang E; Gallon L Clin J Am Soc Nephrol; 2012 Mar; 7(3):504-12. PubMed ID: 22282478 [TBL] [Abstract][Full Text] [Related]
17. Incidence and risk factors associated with cytomegalovirus infection after the treatment of acute rejection during the first year in kidney transplant recipients receiving preemptive therapy. Felipe C; Ferreira AN; de Paula M; Viana L; Cristelli M; Medina Pestana J; Tedesco-Silva H Transpl Infect Dis; 2019 Dec; 21(6):e13106. PubMed ID: 31081566 [TBL] [Abstract][Full Text] [Related]
18. Influence of tacrolimus plus mycophenolate mofetil regimens on acute rejection rate and diabetes mellitus development in renal transplant recipients. Demirbaş A; Tuncer M; Yavuz A; Gürkan A; Kaçar S; Cetinkaya R; Tekin S; Akbaş SH; Akaydin M; Ersoy F; Yakupoğlu G Transplant Proc; 2004; 36(1):175-7. PubMed ID: 15013338 [TBL] [Abstract][Full Text] [Related]